Search research articles
Contact Us
Filters
Showing results (901-910 of 1,547) with videos related to
Page
of 155
Sort By:
Neuro-Oncology
|
September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma
Tracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.
Neuro-Oncology
|
February 22, 2024
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort
Yazmin Odia, Matthew D Hall, Timothy Francis Cloughesy, et al.
Neuro-Oncology
|
November 9, 2019
Biological activity of weekly ONC201 in adult recurrent glioblastoma patients
Isabel Arrillaga-Romany, Yazmin Odia, Varun V Prabhu, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
June 27, 2024
[Long-term outcomes of laparoscopic gastrectomy for locally advanced gastric cancer with serosa-invasion]
P A Li, F Zhang, Z Y Li, et al.
Neuro-Oncology
|
May 29, 2015
Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma
Patrick Y Wen, Antonio Omuro, Manmeet S Ahluwalia, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
June 11, 2019
[Short-term effects of air pollution on lung function of school-age children in Hangzhou]
W Y Liu, L Zhang, H Xu, et al.
Cancer Research
|
August 15, 1990
Specific uptake of the auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans
A I Kassis, A D Van den Abbeele, P Y Wen, et al.
Neuro-Oncology
|
February 8, 2011
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
Patrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
Biotechniques
|
April 19, 2000
Scanning by DOVAM-S detects all unique sequence changes in blinded analyses: evidence that the scanning conditions are generic
C H Buzin, C Y Wen, V Q Nguyen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
December 20, 2020
[Quality assessment of guidelines and consensus in lung cancer chemotherapy]
Y P Zhou, M Yang, P T Yao, et al.
Page
of 155
Search research articles
Search
Showing results (901-910 of 1,547) with videos related to
Sort By:
Page
of 155
Neuro-Oncology
|
September 25, 2016
Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma
Tracy T Batchelor, Elizabeth R Gerstner, Xiaobu Ye, et al.
Neuro-Oncology
|
February 22, 2024
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort
Yazmin Odia, Matthew D Hall, Timothy Francis Cloughesy, et al.
Neuro-Oncology
|
November 9, 2019
Biological activity of weekly ONC201 in adult recurrent glioblastoma patients
Isabel Arrillaga-Romany, Yazmin Odia, Varun V Prabhu, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
June 27, 2024
[Long-term outcomes of laparoscopic gastrectomy for locally advanced gastric cancer with serosa-invasion]
P A Li, F Zhang, Z Y Li, et al.
Neuro-Oncology
|
May 29, 2015
Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma
Patrick Y Wen, Antonio Omuro, Manmeet S Ahluwalia, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]
|
June 11, 2019
[Short-term effects of air pollution on lung function of school-age children in Hangzhou]
W Y Liu, L Zhang, H Xu, et al.
Cancer Research
|
August 15, 1990
Specific uptake of the auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans
A I Kassis, A D Van den Abbeele, P Y Wen, et al.
Neuro-Oncology
|
February 8, 2011
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma
Patrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
Biotechniques
|
April 19, 2000
Scanning by DOVAM-S detects all unique sequence changes in blinded analyses: evidence that the scanning conditions are generic
C H Buzin, C Y Wen, V Q Nguyen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
December 20, 2020
[Quality assessment of guidelines and consensus in lung cancer chemotherapy]
Y P Zhou, M Yang, P T Yao, et al.
Page
of 155